CN111097036A - 眼部护理组合物、产品及其使用方法 - Google Patents
眼部护理组合物、产品及其使用方法 Download PDFInfo
- Publication number
- CN111097036A CN111097036A CN201910369200.7A CN201910369200A CN111097036A CN 111097036 A CN111097036 A CN 111097036A CN 201910369200 A CN201910369200 A CN 201910369200A CN 111097036 A CN111097036 A CN 111097036A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- water
- eye
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 25
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 25
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 25
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000006071 cream Substances 0.000 claims abstract description 13
- 235000000639 cyanocobalamin Nutrition 0.000 claims abstract description 13
- 239000011666 cyanocobalamin Substances 0.000 claims abstract description 13
- -1 hydroxymethyl ester Chemical class 0.000 claims abstract description 9
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 7
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 7
- 239000004410 anthocyanin Substances 0.000 claims abstract description 7
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 7
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 7
- 229960002104 cyanocobalamin Drugs 0.000 claims abstract description 7
- 239000004332 silver Substances 0.000 claims abstract description 7
- 229910052709 silver Inorganic materials 0.000 claims abstract description 7
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 23
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 12
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 12
- 102000008186 Collagen Human genes 0.000 claims description 12
- 108010035532 Collagen Proteins 0.000 claims description 12
- 229960000458 allantoin Drugs 0.000 claims description 12
- 229940124277 aminobutyric acid Drugs 0.000 claims description 12
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 12
- 229920001436 collagen Polymers 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 12
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 12
- 240000008067 Cucumis sativus Species 0.000 claims description 11
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- 229930003799 tocopherol Natural products 0.000 claims description 11
- 229960001295 tocopherol Drugs 0.000 claims description 11
- 239000011732 tocopherol Substances 0.000 claims description 11
- 235000010384 tocopherol Nutrition 0.000 claims description 11
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 11
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 6
- 244000234609 Portulaca oleracea Species 0.000 claims description 6
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 239000010404 Scutellaria baicalensis extract Substances 0.000 claims description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 6
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 239000011648 beta-carotene Substances 0.000 claims description 6
- 235000013734 beta-carotene Nutrition 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 235000019197 fats Nutrition 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- 239000013034 phenoxy resin Substances 0.000 claims description 6
- 229920006287 phenoxy resin Polymers 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 229940057910 shea butter Drugs 0.000 claims description 6
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 6
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000035515 penetration Effects 0.000 claims description 4
- 239000004575 stone Substances 0.000 claims description 4
- 238000001467 acupuncture Methods 0.000 claims description 3
- 235000014121 butter Nutrition 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 210000002435 tendon Anatomy 0.000 claims description 2
- 240000000559 Albizia odoratissima Species 0.000 claims 4
- 208000001491 myopia Diseases 0.000 abstract description 12
- 230000004379 myopia Effects 0.000 abstract description 10
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 7
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 201000009487 Amblyopia Diseases 0.000 abstract description 2
- 241000283690 Bos taurus Species 0.000 abstract description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 abstract description 2
- 201000009310 astigmatism Diseases 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 241000220433 Albizia Species 0.000 description 8
- 241000723353 Chrysanthemum Species 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229950008882 polysorbate Drugs 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
Abstract
本发明提供了一种眼部护理组合物、产品及其使用方法,包括第一水体、第一液体以及第一霜体,所述第一水体包括:水为5至10份、菊花提取物为1‑2份、决明子提取物为0.5‑2份、透明质酸为0.5‑2份、牛硫酸为0.5‑2份、花青素为2‑3份、氰钴氨为0.5‑1份、胍肽‑6为0.5‑2份、羟基甲酯为0.1至‑0.8份、银离子0.01‑0.1份。用于对眼部细胞给予营养,达到修复眼部细胞使眼轴距回走进而缓解近视的目的。本发明的眼部护理组合物,各成分共同发挥作用,针对眼部细胞营养缺失而引起的近视、弱视以及散光等等。达到对眼部提供营养,修复眼睛的细胞,使眼轴距回走进而达到不近视的目的,并且在此过程中不会对人体产生任何伤害以及副作用。
Description
技术领域
本发明涉及眼部护理技术领域,特别涉及一种眼部护理组合物、产品及其使用方法。
背景技术
目前,大部分人都是从学生时代开始近视的,而且近年来,随着社会经济的不断发展,手机、电脑的逐渐普及,我国青少年近视率呈现严重的低龄化趋势。在2017年的世界卫生组织研究报告中指出,我国近视患者人数达到6亿,基本上占据了全国总人口的一半。在这6亿人群中,高中生和大学生的近视率达到了七成以上,而且是呈现不断增长的趋势,市场上急需要一种产品能够对眼部进行护理,使眼部不再近视。
发明内容
本发明提供一种眼部护理组合物、产品及其使用方法,用于对眼部细胞给予营养,达到修复眼部细胞使眼轴距回走进而缓解近视的目的。
一种眼部护理组合物,包括第一水体,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、黄瓜提取物0.5-2份、生育酚0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、寡肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
进一步的,
还包括第一霜体,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、氢化霍霍巴油0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
进一步的,
还包括第一液体,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
一种眼部护理产品,包括用于盛放第一水体的第一盛放装置,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、胍肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
进一步的,
还包括第一霜体以及用于盛放第一霜体的第二盛放装置,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
进一步的,
还包括第一液体以及用于盛放第一液体的第三盛放装置,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
一种眼部护理方法,包括以下步骤:
步骤S1、将第一水体敷于眼部肌肤;
步骤S2、将第一霜体配合砭石眼部拨筋和穴位渗透手法,进行按摩至完全吸收;
步骤S3、将第一液体配合第一霜体位于眼部肌肤使用至吸收。
本发明的其它特征和优点将在随后的说明书中阐述,并且,部分地从说明书中变得显而易见,或者通过实施本发明而了解。本发明的目的和其他优点可通过在所写的说明书、权利要求书、以及附图中所特别指出的结构来实现和获得。
下面通过附图和实施例,对本发明的技术方案做进一步的详细描述。
附图说明
图1为眼部护理方法的流程图。
具体实施方式
以下结合附图对本发明的优选实施例进行说明,应当理解,此处所描述的优选实施例仅用于说明和解释本发明,并不用于限定本发明。
本发明实施例提供了一种眼部护理组合物,包括第一水体,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、黄瓜提取物0.5-2份、生育酚0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、寡肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
在一个实施例中,还包括第一霜体,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
在一个实施例中,还包括第一液体,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
本发明的眼部护理组合物,各成分共同发挥作用,针对眼部细胞营养缺失而引起的近视、弱视以及散光等等。达到对眼部提供营养,修复眼睛的细胞,使眼轴距回走进而达到不近视的目的,并且在此过程中不会对人体产生任何伤害以及副作用。并且经过数据统计,抽查一定数量的近视人群,年龄由8至60岁不等,在使用该产品后裸眼视力恢复到4.8至5.0的人群能够达到百分之97,恢复速度平均为每个月50度左右。对于高度近视的人群,持续使用本产品8~14个月后裸眼视力能够恢复400~500度,经过几个周期使用后,使裸眼视力进入至4.8~5.0。
一种眼部护理产品,包括用于盛放第一水体的第一盛放装置,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、黄瓜提取物0.5-2份、生育酚0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、寡肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
在一个实施例中,还包括第一霜体以及用于盛放第一霜体的第二盛放装置,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
在一个实施例中,还包括第一液体以及用于盛放第一液体的第三盛放装置,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
一种眼部护理方法,如图1所示其流程图,包括以下步骤:
步骤S1、涂抹步骤:将第一水体敷于眼部肌肤;
步骤S2、按摩步骤:将第一霜体配合砭石眼部拨筋和穴位渗透手法,进行按摩至完全吸收;
步骤S3、吸收步骤:将第一液体配合第一霜体位于眼部肌肤使用至吸收。
在眼部护理前,首先清洁眼部肌肤后,取适量第一水体均匀喷于无菌布上敷眼或眼部肌肤,使其自然吸收,缓解改善眼周组织。然后取适量第一霜体配合砭石眼部拨筋和穴位渗透手法,进行按摩至完全吸收。最后通过第一液体配合第一霜体一起使用至吸收。达到细胞吸收营养的目的。
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。
Claims (7)
1.一种眼部护理组合物,其特征在于,包括第一水体,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、黄瓜提取物0.5-2份、生育酚0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、寡肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
2.根据权利要求1所述的眼部护理组合物,其特征在于,
还包括第一霜体,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、氢化霍霍巴油0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
3.根据权利要求1所述的眼部护理组合物,其特征在于,
还包括第一液体,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
4.一种眼部护理产品,其特征在于,包括用于盛放第一水体的第一盛放装置,所述第一水体包括:
水为5至10份、菊花提取物为1-2份、决明子提取物为0.5-2份、黄瓜提取物0.5-2份、生育酚0.5-2份、透明质酸为0.5-2份、牛硫酸为0.5-2份、花青素为2-3份、氰钴氨为0.5-1份、寡肽-6为0.5-2份、羟基甲酯为0.1至-0.8份、银离子0.01-0.1份。
5.根据权利要求4所述的眼部护理组合物,其特征在于,
还包括第一霜体以及用于盛放第一霜体的第二盛放装置,所述第一霜体包括:
水为5-10份、甘油为1-4份、丁二醇为1-2份、β-胡萝卜素为0.5-4份、氨基丁酸为0.5-1份、氢化霍霍巴油0.5-1份、异壬酸异壬酯为0.1-1份、聚甘油-3甲基葡萄糖苷二硬脂酸酯为0.1-0.8份、牛油果树提取物为0.1-0.8份、脂果脂油为0.1-0.5份、生育酚(维生素E)为0.1-0.5份、黄瓜提取物为0.1-1份、海藻糖为1-2份、透明质酸为0.5-1.5份、尿囊素为0.1-0.5份、合欢树皮提取物为0.1-0.5份、黄芩提取物为0.1-0.5份、胶原提取物为0.1-0.5份、透明质酸为0.1-1份、聚山梨醇脂-20为0.1-1份、苯氧乙醇-200为0.1-0.8份、乙基乙基甘油为0.1-1份。
6.根据权利要求4所述的眼部护理组合物,其特征在于,
还包括第一液体以及用于盛放第一液体的第三盛放装置,所述第一液体包括:
水为5-10份、丁二醇为1-4份、甘油为1-4份、1,2戊二醇为1-2份、氰钴胺为1-2份、氨基丁酸为1-2份、马齿笕提取物为0.1-1、蛇床子提取物为0.1-1、酵母菌溶胞物提取物为0.1-1、尿囊素为0.1-0.5份、透明质酸为0.1-0.8份、寡肽-6为0.5-2份、牛磺酸为0.1-0.8份、透明质酸钠为0.1-0.8份、合欢树皮提取物为0.1-0.5份、胶原提取物为0.1-0.5份、苯氧乙醇为0.1-0.5份。
7.一种眼部护理方法,其特征在于,包括以下步骤:
步骤S1、将第一水体敷于眼部肌肤;
步骤S2、将第一霜体配合砭石眼部拨筋和穴位渗透手法,进行按摩至完全吸收;
步骤S3、将第一液体配合第一霜体位于眼部肌肤使用至吸收。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910369200.7A CN111097036A (zh) | 2019-05-05 | 2019-05-05 | 眼部护理组合物、产品及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910369200.7A CN111097036A (zh) | 2019-05-05 | 2019-05-05 | 眼部护理组合物、产品及其使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111097036A true CN111097036A (zh) | 2020-05-05 |
Family
ID=70420409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910369200.7A Pending CN111097036A (zh) | 2019-05-05 | 2019-05-05 | 眼部护理组合物、产品及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111097036A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239707A (zh) * | 2013-05-22 | 2013-08-14 | 江苏紫石化工科技有限公司 | 治疗近视的滴眼液 |
US20130315846A1 (en) * | 2012-05-22 | 2013-11-28 | Mary Kay Inc. | Cosmetic compositions |
CN105106049A (zh) * | 2015-08-19 | 2015-12-02 | 周南燕 | 一种用于眼部护理的组合物及制备方法 |
US20150342854A1 (en) * | 2012-12-27 | 2015-12-03 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
CN105963677A (zh) * | 2016-05-03 | 2016-09-28 | 宋钦 | 一种眼部护理凝胶及其制备方法 |
CN109010761A (zh) * | 2018-08-15 | 2018-12-18 | 王小平 | 一种缓解视疲劳和提高视力的眼部外用药及其制备方法 |
CN109260136A (zh) * | 2018-11-29 | 2019-01-25 | 福建天眼视界健康科技有限公司 | 一种护眼霜及其制备方法 |
-
2019
- 2019-05-05 CN CN201910369200.7A patent/CN111097036A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130315846A1 (en) * | 2012-05-22 | 2013-11-28 | Mary Kay Inc. | Cosmetic compositions |
US20150342854A1 (en) * | 2012-12-27 | 2015-12-03 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
CN103239707A (zh) * | 2013-05-22 | 2013-08-14 | 江苏紫石化工科技有限公司 | 治疗近视的滴眼液 |
CN105106049A (zh) * | 2015-08-19 | 2015-12-02 | 周南燕 | 一种用于眼部护理的组合物及制备方法 |
CN105963677A (zh) * | 2016-05-03 | 2016-09-28 | 宋钦 | 一种眼部护理凝胶及其制备方法 |
CN109010761A (zh) * | 2018-08-15 | 2018-12-18 | 王小平 | 一种缓解视疲劳和提高视力的眼部外用药及其制备方法 |
CN109260136A (zh) * | 2018-11-29 | 2019-01-25 | 福建天眼视界健康科技有限公司 | 一种护眼霜及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340813A (zh) | 一种胶原护肤乳液及其制备方法和应用 | |
CN102139038A (zh) | 一种治疗眼病的中药制剂 | |
CN112263528A (zh) | 一种胶原蛋白果冻面膜及其制备和使用方法 | |
CN112107533A (zh) | 一种具有控油嫩肤并收细毛孔功效的组合物及其制备方法和应用 | |
CN112190617A (zh) | 一种缓解眼部疲劳的营养液及其制备方法 | |
CN110974729A (zh) | 一种祛眼袋眼霜及其制备方法 | |
CN104383168A (zh) | 一种提高视力的中药药膏及其制备方法 | |
CN106309260A (zh) | 一种三七驻颜面膜 | |
CN111097036A (zh) | 眼部护理组合物、产品及其使用方法 | |
CN110279606B (zh) | 一种祛黑眼圈、抗衰补水的眼膜液及其制备方法 | |
CN103271854B (zh) | 一种促进睡眠的精油按摩剂及其制备方法 | |
CN107308028A (zh) | 透皮给药精华液 | |
CN101647913B (zh) | 一种治疗老年性白内障和病毒性角膜炎的中药制剂 | |
CN106073363B (zh) | 一种对近视眼有显著疗效的菊花香枕 | |
CN108485848A (zh) | 一种含水凝胶相颗粒的洗发皂及其制备方法 | |
CN112999124A (zh) | 一种护眼喷雾及其制备方法 | |
CN113713022A (zh) | 一种护眼液及其制备方法和应用 | |
CN109288714A (zh) | 一种防蓝光辐射的眼霜及其制备方法 | |
Ranneva et al. | New medical approach for rejuvenation of the periorbital area | |
RU2807377C1 (ru) | Способ проведения гирудотерапии для коррекции возрастных изменений кожи лица | |
CN110693729A (zh) | 一种沙棘油面膜及其制备方法 | |
CN110327433B (zh) | 一种使眼角上扬、眼部放松的液体制剂 | |
CN110463887A (zh) | 一种中药美白保健饮料及其制备方法 | |
CN107638371A (zh) | 一种含有何首乌干细胞提取物的祛眼袋组合物及其应用 | |
CN104644525A (zh) | 一种温和滋润型洗面奶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |